Morepen Labs incorporates new step-down subsidiary in mainland Dubai

Published On 2025-07-23 07:14 GMT   |   Update On 2025-07-23 07:14 GMT
Advertisement

Gurugram: Morepen Laboratories Limited has announced the incorporation of a new step-down subsidiary, Morepen Medical Equipment Trading L.L.C, in mainland Dubai, United Arab Emirates (UAE).

The newly incorporated entity is a wholly owned subsidiary of Morepen Medipath Limited (formerly Morepen Medtech Limited) and aims to focus on the sales and marketing of medical devices' products in the international market including Dubai, U.A.E., and others.

Morepen Labs indirectly holds a 60% of the shares in the Dubai-based company through Morepen Medipath.

Morepen Medipath Limited has subscribed 100 shares, of AED 1000 each, for an aggregate amount of AED 100000. The denomination of share has been changed from AED 10 each to AED 1000 each, however, the total capital, being AED 100000 remain unchanged.

Read also: CDSCO panel grants clearance to Morepen Labs to conduct BE studies for fatty liver disease drug Resmetirom

Advertisement

The new subsidiary, incorporated on July 22, 2025, will operate in the medical devices segment.

In June, Medical Dialogues reported the incorporation of MOREPEN LABS - FZCO, a wholly owned subsidiary of Morepen Labs in Dubai.

Read also: Morepen Labs incorporates wholly owned subsidiary in Dubai

In April, the company also announced an expansion of its salesforce, with plans to onboard over 1,000 professionals over the next three years. Of these, 200 new team members are expected to join in FY26. The recruitment drive is part of Morepen’s strategy to strengthen engagement with doctors, pharmacies, patients, and healthcare professionals across India.

Morepen Laboratories Ltd. is an Indian pharmaceutical company with a global footprint across 82 countries. All APIs are manufactured in-house at USFDA-approved facilities.

Read also: Morepen Labs plans to employ over 1000 professionals

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News